Clinical Trial Update: A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of varenicline in Japanese smokers motivated to quit; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking | Phase 2 | Status: COMPLETED